首页|期刊导航|基因与疾病(英文)|Molecular characterization analysis of PANoptosis subtyping and identification of elastin as a novel therapeutic target in colorectal cancer

Molecular characterization analysis of PANoptosis subtyping and identification of elastin as a novel therapeutic target in colorectal cancerOA

Molecular characterization analysis of PANoptosis subtyping and identification of elastin as a novel therapeutic target in colorectal cancer

Yongmin Li;Dongxu Liu;Yiming Ma;Yu Liang;Yupeng Ren;Qingkai Meng;Bin Ma

Department of Colorectal Surgery,Cancer Hospital of China Medical University,Cancer Hospital of Dalian University of Technology,Liaoning Cancer Hospital &Institute,Shenyang,Liaoning 110042,ChinaDepartment of Colorectal Surgery,Cancer Hospital of China Medical University,Cancer Hospital of Dalian University of Technology,Liaoning Cancer Hospital &Institute,Shenyang,Liaoning 110042,ChinaDepartment of Medical Oncology,Cancer Hospital of China Medical University,Cancer Hospital of Dalian University of Technology,Liaoning Cancer Hospital &Institute,Shenyang,Liaoning 110042,ChinaDepartment of Colorectal Surgery,Cancer Hospital of China Medical University,Cancer Hospital of Dalian University of Technology,Liaoning Cancer Hospital &Institute,Shenyang,Liaoning 110042,ChinaDepartment of Colorectal Surgery,Cancer Hospital of China Medical University,Cancer Hospital of Dalian University of Technology,Liaoning Cancer Hospital &Institute,Shenyang,Liaoning 110042,ChinaDepartment of Colorectal Surgery,Cancer Hospital of China Medical University,Cancer Hospital of Dalian University of Technology,Liaoning Cancer Hospital &Institute,Shenyang,Liaoning 110042,ChinaDepartment of Colorectal Surgery,Cancer Hospital of China Medical University,Cancer Hospital of Dalian University of Technology,Liaoning Cancer Hospital &Institute,Shenyang,Liaoning 110042,China

《基因与疾病(英文)》 2026 (1)

10-13,4

This work was supported by the Cultivation Program of National Science Foundation of Liaoning Cancer Hospital(No.2021-ZLLH-03),the Medical and Industrial Cross Joint Fund of Dalian University of Technology-Liaoning Cancer Hospital(No.LD2023027),the Liaoning Province Science and Technology Plan Joint Program(Applied Basic Research Project)(China)(No.2023JH2/101700150),and the National Natural Science Foundation of China(No.82303131).

10.1016/j.gendis.2025.101560

评论